Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.
about
Ghrelin for the management of cachexia associated with cancerRole of Inflammation in Muscle Homeostasis and MyogenesisThe quasi-parallel lives of satellite cells and atrophying muscleAnkyrin repeat domain protein 2 and inhibitor of DNA binding 3 cooperatively inhibit myoblast differentiation by physical interactionDistinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and diseaseDexmedetomidine post-treatment induces neuroprotection via activation of extracellular signal-regulated kinase in rats with subarachnoid haemorrhageGhrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.Vitamin D and VDR in cancer cachexia and muscle regeneration.Inflammation based regulation of cancer cachexiaSkeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1Skeletal muscle and motor deficits in Neurofibromatosis Type 1.Quercetin protects against obesity-induced skeletal muscle inflammation and atrophy.Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exerciseTNF-α and IGF1 modify the microRNA signature in skeletal muscle cell differentiationRole of TGF-β signaling in inherited and acquired myopathies.Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wastingSunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer.A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.Mechanisms of Cachexia in Chronic Disease StatesJAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes.Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wastingSpontaneous Physical Activity Downregulates Pax7 in Cancer CachexiaCancer cachexia causes skeletal muscle damage via transient receptor potential vanilloid 2-independent mechanisms, unlike muscular dystrophySTAT3 in the systemic inflammation of cancer cachexia.Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia.Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes.Isolation, characterization, and molecular regulation of muscle stem cells.Age-associated repression of type 1 inositol 1, 4, 5-triphosphate receptor impairs muscle regeneration.Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs.The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia.The MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia.Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches.Novel investigational drugs mimicking exercise for the treatment of cachexia.Cancer-induced muscle wasting: latest findings in prevention and treatment.Skeletal muscle regeneration in cancer cachexia.
P2860
Q26471773-FAD86BF1-7C0B-4F89-A280-8399FE1B72BAQ26778322-3AE11CC8-C89A-43FE-91A7-63AF9C2243C2Q26800207-4E3BD914-7E74-46DB-B1E3-FF42B7272EF4Q28507013-E51B2796-FD5D-479E-91AC-76B3CC44FC97Q28542391-F4CD5814-5F52-431D-B49C-2C8BA68D9E44Q28606560-B943FBF7-EBFD-4AC0-B879-CEB0822B8A92Q30277368-0DFC5305-AACE-410A-9023-E5C214610B6DQ30384810-D1E7F2C7-426F-4B7E-AFFB-ED9C7B752857Q33591678-10A97C44-DCA0-4D24-8AA7-E27C3E318FD1Q33615916-63DCE1E5-8F58-4CCF-9868-40A127ACA421Q34200869-2B454E05-2EFF-4C5E-B97E-CACB1C29D70AQ34478793-A24A8306-4343-47AD-B3E0-36106AD2D1D8Q34970397-00358647-58D3-4AA0-9C81-28798F7F03D8Q35053606-8BE36E33-DFFC-496A-AB95-1BDBA05411F6Q35077416-BF18E990-5F61-4C7B-91DC-BC0EF4FC1EFBQ35166254-9A04108B-BBBA-479C-AB4F-899EA964B5C0Q35341311-D59D5BA4-9F1E-4B5C-BC6E-67F31664CBA1Q35422257-795B272E-4A95-4138-A155-A880751D548DQ35550169-38605A1D-4026-4740-A148-3653A9F659B8Q35759017-9B1D2C6A-172F-4351-A78F-C2956FE0CD89Q35925919-78A4DAA7-BE63-47CB-AD94-FF0836C5D4C1Q36103986-6636EF7F-F1E8-4ADB-BFCB-D6B3D25BAF2BQ36176015-C526A86C-A0CC-44A5-9960-FDB3D3E784BCQ36422693-78D99EFE-81FD-4E9E-8907-F8240858E329Q36686835-4E900CAB-D41E-4A5F-AF57-40C5923B05D6Q36726861-59177ABC-3D86-4661-9BAA-C430AE8B6856Q36893355-0FBEE477-9BA3-4A67-BE72-F66D1CF654E5Q36901910-AA8919E1-424F-42EE-B21B-B6331A8E0895Q37042189-C0EB282F-2851-4786-87F9-36632FE23FFAQ37259234-B8420B2A-5E3D-4EF4-B50F-86A0834633A7Q37282125-49788626-F131-4399-9A4C-C6866961C894Q37298113-BFAA5955-952B-4905-97F2-EB0975583AA7Q37361047-645ED715-A298-42D0-B2F8-2548522C12CAQ37536603-B5569141-0B20-4972-9959-B1E50AF869A6Q37580016-A9A66021-A026-4633-A548-2998D25B90C7Q37590551-6C63DF44-AA6D-40FD-9B63-D316CD6F40C0Q38587970-5227A073-D9F8-4CFA-B15A-A58A28944C02Q38631222-61284EEB-43C3-463E-8350-AF4739DFC229Q38681113-0E47C3AD-2F5E-4642-A14E-A2D4AB21D149Q38726702-38F35744-B6D4-420A-8547-33DB4EA483B5
P2860
Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Muscle wasting and impaired my ...... e prevented by ERK inhibition.
@ast
Muscle wasting and impaired my ...... e prevented by ERK inhibition.
@en
type
label
Muscle wasting and impaired my ...... e prevented by ERK inhibition.
@ast
Muscle wasting and impaired my ...... e prevented by ERK inhibition.
@en
prefLabel
Muscle wasting and impaired my ...... e prevented by ERK inhibition.
@ast
Muscle wasting and impaired my ...... e prevented by ERK inhibition.
@en
P2093
P2860
P1433
P1476
Muscle wasting and impaired my ...... re prevented by ERK inhibition
@en
P2093
Alessandro Fanzani
Domiziana Costamagna
Francesco M Baccino
Paola Costelli
P2860
P304
P356
10.1371/JOURNAL.PONE.0013604
P407
P577
2010-10-27T00:00:00Z